Ralf Clemens

Best Publications

• Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

  Guillermo M. Ruiz-Palacios;Irene Pérez-Schael;F. Raúl Velázquez;Hector Abate

  2352
  Citations

• Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

  Unknown

  730
  Citations

• Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

  Martin Alberer;Ulrike Gnad-Vogt;Henoch Sangjoon Hong;Keyvan Tadjalli Mehr

  541
  Citations

• Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

  Steven Black;Uwe Nicolay;Timo Vesikari;Markus Knuf

  442
  Citations

• Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

  Timo Vesikari;Markus Knuf;Peter Wutzler;Aino Karvonen

  418
  Citations

• Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

  Unknown

  356
  Citations

• Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

  Emmet B. Keeffe;Sten Iwarson;Brian J. McMahon;Karen L. Lindsay

  340
  Citations

• Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults

  David I. Bernstein;Robert L. Atmar;G. Marshall Lyon;John J. Treanor

  299
  Citations

• Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.

  Peter Richmond;Lara Hatchuel;Min Dong;Brenda Ma

  292
  Citations

• Clinical Experience With An Inactivated Hepatitis A Vaccine

  Unknown

  285
  Citations

• Blood Stage Antimalarial Efficacy of Primaquine in Plasmodium vivax Malaria

  Sasithon Pukrittayakamee;Sirivan Vanijanonta;Arun Chantra;Ralf Clemens

  174
  Citations

• A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate—Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

  John J. Treanor;Robert L. Atmar;Sharon E. Frey;Robert Gormley

  173
  Citations

• The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

  Pierre Van Damme;Ilse De Coster;Ananda S Bandyopadhyay;Hilde Revets

  155
  Citations

• Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway

  R. Clemens;C. Pramoolsinsap;R. Lorenz;S. Pukrittayakamee

  137
  Citations

• Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b - PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine

  F. Zepp;H.-J. Schmitt;A. Kaufhold;A. Schuind

  136
  Citations

• Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

  F Zepp;M Knuf;P Habermehl;J H Schmitt

  132
  Citations

• Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy.

  Theodore F. Tsai;Antonio Crucitti;Pantaleo Nacci;Uwe Nicolay

  132
  Citations

• Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance

  Ralf Clemens;Roland Sänger;Johannes Kruppenbacher;Wilfried Höbel

  131
  Citations

• Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil

  Unknown

  113
  Citations

• Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

  Unknown

  112
  Citations